Diffusion-weighted MRI for assessment of early cancer treatment response

Current Pharmaceutical Biotechnology

Volumn 11, Issue 6, 2010, Pages 701-708

  Galbán, Stefanie ^a   Brisset, Jean Christophe ^b   Rehemtulla, Alnawaz ^a,b   Chenevert, Thomas L ^b   Ross, Brian D ^b   Galbán, Craig J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apparent diffusion coefficient; Cancer; DW MRI; Imaging biomarker; Treatment response

Indexed keywords

BONE CANCER; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CELL DENSITY; CELL HETEROGENEITY; CELL VOLUME; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; GLIA CELL; GLIOMA; HEAD AND NECK CARCINOMA; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; METASTASIS; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; REVIEW; SPINE CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR VOLUME; WORLD HEALTH ORGANIZATION; GENETIC PROCEDURES; IMAGE ENHANCEMENT; METHODOLOGY; MOLECULAR IMAGING; MOLECULAR PROBE; NEOPLASM; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME;

DIAGNOSTIC AGENT;

DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; MOLECULAR IMAGING; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 79952117784     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110792246627     Document Type: Review

References (41)

1. Gehan, E.A.; Schneiderman, M.A. Historical and methodological developments in clinical trials at the National Cancer Institute. Stat. Med. 1990, 9. 871-880; discussion 903-876.
2. World Health Organization.: WHO handbook for reporting results of cancer treatment. Geneva, The Organization, 1979.
3. Therasse, P.; Arbuck, S.G.; Eisenhauer, E.A.; Wanders, J.; Kaplan, R.S.; Rubinstein, L.; Verweij, J.; Van Glabbeke, M.; van Oosterom, A.T.; Christian, M.C.; Gwyther, S.G. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 2000, 92. 205-216.
4. Jaffe, C.C. Measures of response: RECIST, WHO, and new alternatives. J. Clin. Oncol. 2006, 24. 3245-3251.
5. Choi, H.; Charnsangavej, C.; de Castro Faria, S.; Tamm, E.P.; Benjamin, R.S.; Johnson, M.M.; Macapinlac, H.A.; Podoloff, D.A. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. Am. J. Roentgenol. 2004, 183. 1619-1628.
6. Strumberg, D.; Richly, H.; Hilger, R.A.; Schleucher, N.; Korfee, S.; Tewes, M.; Faghih, M.; Brendel, E.; Voliotis, D.; Haase, C.G.; Schwartz, B.; Awada, A.; Voigtmann, R.; Scheulen, M.E.; Seeber, S. Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J. Clin. Oncol. 2005, 23. 965-972.
7. Stejskal, E.; Tanner, J. Spin diffusion measurements: Spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 1965, 42. 288-292.
8. Le Bihan, D. Molecular diffusion nuclear magnetic resonance imaging. Magn. Reson. Q. 1991, 7. 1-30.
9. Le Bihan, D.; Breton, E.; Lallemand, D.; Aubin, M.L.; Vignaud, J.; Laval-Jeantet, M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988, 168. 497-505.
10. Le Bihan, D. The 'wet mind': water and functional neuroimaging. Phys. Med. Biol. 2007, 52. R57-90.
11. Schaefer, P.W.; Grant, P.E.; Gonzalez, R.G. Diffusion-weighted MR imaging of the brain. Radiology. 2000, 217. 331-345.
12. Hamstra, D.A.; Rehemtulla, A.; Ross, B.D. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J. Clin. Oncol. 2007, 25. 4104-4109.
13. Anderson, A.W.; Xie, J.; Pizzonia, J.; Bronen, R.A.; Spencer, D.D.; Gore, J.C. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn. Reson. Imaging. 2000, 18. 689-695.
14. Humphries, P.D.; Sebire, N.J.; Siegel, M.J.; Olsen, O.E. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology. 2007, 245. 848-854.
15. Kinoshita, M.; Hashimoto, N.; Goto, T.; Kagawa, N.; Kishima, H.; Izumoto, S.; Tanaka, H.; Fujita, N.; Yoshimine, T. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage. 2008, 43. 29-35.
16. Zelhof, B.; Pickles, M.; Liney, G.; Gibbs, P.; Rodrigues, G.; Kraus, S.; Turnbull, L. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int. 2009, 103(7), 883-8.
17. Moffat, B.A.; Chenevert, T.L.; Lawrence, T.S.; Meyer, C.R.; Johnson, T.D.; Dong, Q.; Tsien, C.; Mukherji, S.; Quint, D.J.; Gebarski, S.S.; Robertson, P.L.; Junck, L.R.; Rehemtulla, A.; Ross, B.D. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc. Natl. Acad. Sci. USA. 2005, 102. 5524-5529.
18. Lustig, R.A.; Seiferheld, W.; Berkey, B.; Yung, A.W.; Scarantino, C.; Movsas, B.; Jones, C.U.; Simpson, J.R.; Fishbach, J.; Curran, W.J. Jr., Imaging response in malignant glioma, RTOG 90-06. Am. J. Clin. Oncol. 2007, 30. 32-37.
19. Macdonald, D.R.; Cascino, T.L.; Schold, S.C., Jr.; Cairncross, J.G. Response criteria for phase II studies of supratentorial malignant glioma. J. Clin. Oncol. 1990, 8. 1277-1280.
20. Stupp, R.; Mason, W.P.; van den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M.J.; Belanger, K.; Brandes, A.A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R.C.; Ludwin, S.K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J.G.; Eisenhauer, E.; Mirimanoff, R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352. 987-996.
21. Chenevert, T.L.; Stegman, L.D.; Taylor, J.M.; Robertson, P.L.; Greenberg, H.S.; Rehemtulla, A.; Ross, B.D. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J. Natl. Cancer Inst. 2000, 92. 2029-2036.
22. Mardor, Y.; Roth, Y.; Lidar, Z.; Jonas, T.; Pfeffer, R.; Maier, S.E.; Faibel, M.; Nass, D.; Hadani, M.; Orenstein, A.; Cohen, J.S.; Ram, Z. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res. 2001, 61. 4971-4973.
23. Mardor, Y.; Pfeffer, R.; Spiegelmann, R.; Roth, Y.; Maier, S.E.; Nissim, O.; Berger, R.; Glicksman, A.; Baram, J.; Orenstein, A.; Cohen, J.S.; Tichler, T. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J. Clin. Oncol. 2003, 21. 1094-1100.
24. Jager, H.R.; Waldman, A.D.; Benton, C.; Fox, N.; Rees, J. Differential chemosensitivity of tumor components in a malignant oligodendroglioma: assessment with diffusion-weighted, perfusionweighted, and serial volumetric MR imaging. Am. J. Neuroradiol. 2005, 26. 274-278.
25. Lidar, Z.; Mardor, Y.; Jonas, T.; Pfeffer, R.; Faibel, M.; Nass, D.; Hadani, M.; Ram, Z. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J. Neurosurg. 2004, 100. 472-479.
26. Schubert, M.I.; Wilke, M.; Muller-Weihrich, S.; Auer, D.P. Diffusion-weighted magnetic resonance imaging of treatmentassociated changes in recurrent and residual medulloblastoma: preliminary observations in three children. Acta Radiol. 2006, 47. 1100-1104.
27. Huang, C.F.; Chou, H.H.; Tu, H.T.; Yang, M.S.; Lee, J.K.; Lin, L.Y. Diffusion magnetic resonance imaging as an evaluation of the response of brain metastases treated by stereotactic radiosurgery. Surg. Neurol. 2008, 69. 62-68; discussion 68.
28. Tomura, N.; Narita, K.; Izumi, J.; Suzuki, A.; Anbai, A.; Otani, T.; Sakuma, I.; Takahashi, S.; Mizoi, K.; Watarai, J. Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J. Comput. Assist Tomogr. 2006, 30. 496-500.
29. Hamstra, D.A.; Chenevert, T.L.; Moffat, B.A.; Johnson, T.D.; Meyer, C.R.; Mukherji, S.K.; Quint, D.J.; Gebarski, S.S.; Fan, X.; Tsien, C.I.; Lawrence, T.S.; Junck, L.; Rehemtulla, A.; Ross, B.D. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc. Natl. Acad. Sci. USA. 2005, 102. 16759-16764.
30. Hamstra, D.A.; Galban, C.J.; Meyer, C.R.; Johnson, T.D.; Sundgren, P.C.; Tsien, C.; Lawrence, T.S.; Junck, L.; Ross, D.J.; Rehemtulla, A.; Ross, B.D.; Chenevert, T.L. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J. Clin. Oncol. 2008, 26. 3387-3394.
31. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58. 71-96.
32. Kim, S.; Loevner, L.; Quon, H.; Sherman, E.; Weinstein, G.; Kilger, A.; Poptani, H. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin. Cancer Res. 2009, 15. 986-994.
33. Galban, C.J.; Mukherji, S.K.; Chenevert, T.L.; Meyer, C.R.; Hamstra, D.A.; Bland, P.H.; Johnson, T.D.; Moffat, B.A.; Rehemtulla, A.; Eisbruch, A.; Ross, B.D. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl. Oncol. 2009, 2. 184-190.
34. Byun, W.M.; Shin, S.O.; Chang, Y.; Lee, S.J.; Finsterbusch, J.; Frahm, J. Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy. Am. J. Neuroradiol. 2002, 23. 906-912.
35. Lee, K.C.; Bradley, D.A.; Hussain, M.; Meyer, C.R.; Chenevert, T.L.; Jacobson, J.A.; Johnson, T.D.; Galban, C.J.; Rehemtulla, A.; Pienta, K.J.; Ross, B.D. A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia. 2007, 9. 1003-1011.
36. Dzik-Jurasz, A.; Domenig, C.; George, M.; Wolber, J.; Padhani, A.; Brown, G.; Doran, S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002, 360. 307-308.
37. Hein, P.A.; Kremser, C.; Judmaier, W.; Griebel, J.; Pfeiffer, K.P.; Kreczy, A.; Hug, E.B.; Lukas, P.; DeVries, A.F. Diffusionweighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur. J. Radiol., 2003, 45. 214-222.
38. Kremser, C.; Judmaier, W.; Hein, P.; Griebel, J.; Lukas, P.; de Vries, A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol. 2003, 179. 641-649.
39. Jacobs, M.A.; Herskovits, E.H.; Kim, H.S. Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery--preliminary study. Radiology. 2005, 236. 196-203.
40. Padhani, A.R.; Liu, G.; Mu-Koh, D.; Chenevert, T.L.; Thoeny, H.C.; Takahara, T.; Dzik-Jurasz, A.; Ross, B.D.; Van Cauteren, M.; Collins, D.; Hammoud, D.A.; Rustin, G.J.; Taouli, B.; Choyke, P.L. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009, 11. 102-125.
41. Kwee, T.C.; Takahara, T.; Ochiai, R.; Nievelstein, R.A.; Luijten, P.R. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur. Radiol. 2008, 18. 1937-1952.